Quarterly report pursuant to sections 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)

v2.4.0.6
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) (USD $)
3 Months Ended 181 Months Ended
Mar. 31, 2013
Mar. 31, 2012
Mar. 31, 2013
Income Statement [Abstract]      
Net sales       $ 69,000
Cost of goods sold       24,120
Gross profit       44,880
Operating expenses 1,212,884 1,869,905 52,283,189
Research and development expenses 329,055 235,466 8,998,736
Non-cash patent settlement cost       1,610,066
Loss before other income (expense) (1,541,939) (2,105,371) (62,847,111)
Other income (expense) (28,845) 13,591 187,850
Interest income       16,342
Interest and financing expense (260) (2,462,867) (20,304,609)
Change in fair value of derivative liabilities (220,614) (1,139,477) (2,115,507)
Gain on extinguishment of derivative liabilities 3,441,752    5,886,847
Costs of private placement       (1,640,715)
Costs to induce conversion of notes       (469,043)
Loss on disposition of equipment       (14,426)
Settlement of Debt Due Morale/ Matthews       (927,903)
Settlement of litigation and debt (67,294) 223,774 1,437,503
Income (loss) before provision for income taxes 1,582,800 (5,470,350) (80,790,772)
Provision for income taxes       8,282
Net income (loss) $ 1,582,800 $ (5,470,350) $ (80,799,054)
Net income (loss) per common share, basic $ 0.01 $ (0.05)  
Net income (loss) per common share, diluted $ 0.01 $ (0.05)  
Weighted average common shares outstanding, basic 150,112,286 118,213,662  
Weighted average common shares outstanding, diluted 172,461,669 118,213,662